Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus
Evidence in Focus, February 2022
Read Published ArticleThis evidence in focus systematically reviews available clinical trial data detailing aducanumab use in individuals with early symptomatic Alzheimer disease and presents clinical considerations regarding use.
Patient Tools and Materials
Patient Q&A
Download a list of patient and care partner questions and answers about this guideline product